Skip to content

Inhibrx Biosciences, Inc. (INBX) Insider Trading -- Recent Executive & Director Transactions

12 insiders reported 43 Form 4 transactions for Inhibrx Biosciences, Inc. (INBX) over the past 18 months (most recent 2026-09-28). Recent activity: Lappe Mark (Chief Executive Officer) Buy 3,324 shares, Lappe Mark (Chief Executive Officer) Buy 2,176 shares, Lappe Mark (Chief Executive Officer) Buy 1,500 shares, Lappe Mark (Chief Executive Officer) Buy 3,000 shares, Kayyem Jon Faiz (Director) Buy 5,000 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-09-28Lappe MarkChief Executive OfficerBuy3,324$328,630
2026-09-28Lappe MarkChief Executive OfficerBuy2,176$216,727
2026-09-28Lappe MarkChief Executive OfficerBuy1,500$148,320
2026-09-28Lappe MarkChief Executive OfficerBuy3,000$305,106
2026-09-23Kayyem Jon FaizDirectorBuy5,000$500,000
2026-09-17Kayyem Jon FaizDirectorBuy5,000$500,000
2026-09-15MANHARD KIMBERLYDirectorSell500$55,888
2026-09-15MANHARD KIMBERLYDirectorSell500$55,130
2026-09-15MANHARD KIMBERLYDirectorSell500$52,525
2026-09-10MANHARD KIMBERLYDirectorSell500$57,570
2026-09-10MANHARD KIMBERLYDirectorSell500$57,898
2026-09-08FORSYTH DOUGLASDirectorBuy2,500$286,617
2026-09-08Kayyem Jon FaizDirectorBuy5,000$567,580
2026-09-08Lappe MarkChief Executive OfficerBuy6,605$664,719
2026-09-08Lappe MarkChief Executive OfficerBuy1,100$117,836
2026-09-08Lappe MarkChief Executive OfficerBuy500$54,118
2026-09-08Lappe MarkChief Executive OfficerBuy1,219$136,382
2026-09-08Lappe MarkChief Executive OfficerBuy9,681$1.1M
2026-09-08Lappe MarkChief Executive OfficerBuy5,895$585,343
2025-10-09Viking Global Opportunities Illiquid Investments Sub-Master LP10% OwnerSell308,643$10.0M
2025-10-09VIKING GLOBAL INVESTORS LP10% OwnerSell308,643$10.0M
2025-10-09HALVORSEN OLE ANDREAS10% OwnerSell308,643$10.0M
2025-10-09Ott David C.10% OwnerSell308,643$10.0M
2025-10-09Viking Global Opportunities Portfolio GP LLC10% OwnerSell308,643$10.0M
2025-10-09Viking Global Opportunities GP LLC10% OwnerSell308,643$10.0M

Source: SEC Form 4 filings · as of 2026-09-28